Position in AMGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$25,816,983
+$827,541 QoQ
Shares Held
71,294
+0.4% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
2.95%
of 13F equity value
Holder Rank
#330
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GREATMARK INVESTMENT PARTNERS, INC. holds $72,037,606 across 8 Drug Manufacturers - General names. AMGN ranks #2 (35.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
114,692 | $29,128,327 | |
| 2 | AMGN |
Amgen Inc
This page
|
71,294 | $25,816,983 | |
| 3 | ABBV |
AbbVie Inc.
|
36,732 | $9,243,240 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
28,312 | $3,576,938 | |
| 5 | LLY |
ELI LILLY & Co
|
2,673 | $3,206,076 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,806 | $489,071 | |
| 7 | AZN |
Astrazeneca PLC
|
1,821 | $345,298 | |
| 8 | PFE |
Pfizer Inc
|
9,621 | $231,673 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,816,983 | 71,294 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $24,989,442 | 71,023 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $23,157,509 | 70,751 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $20,403,906 | 72,303 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $20,171,526 | 72,245 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $22,006,957 | 70,637 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $17,936,202 | 68,816 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $20,967,171 | 65,073 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $20,331,746 | 65,072 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $18,353,993 | 64,554 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $18,003,842 | 62,509 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $16,744,823 | 62,304 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $14,164,876 | 63,800 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $14,708,795 | 60,843 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $16,497,468 | 62,814 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $14,377,589 | 63,787 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $15,262,695 | 62,732 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $15,157,277 | 62,680 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $13,058,383 | 58,045 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $9,493,333 | 44,643 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $9,122,831 | 37,427 | Shares | Sole | 2021-08-23 | |
| 2021-03-31 | $3,753,547 | 15,086 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $3,117,485 | 13,559 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,870,109 | 7,358 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $1,702,437 | 7,218 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $1,431,881 | 7,063 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||